How do we help?

Our group of prognostic and predictive blood biomarkers – GlyHealth,  reliably measure and track chronic inflammation processes in the body. Unlike current inflammation markers, this is done without interference from acute inflammation and can give early warning signs even at very early subclinical stages of inflammatory diseases. Blood tests based on these biomarkers can also be used to track fitness of immune system and effectiveness of anti-inflammatory intervention.

Individuals​

We help: Diagnosed patients with inflammatory conditions such as Inflammatory Bowel Disease or at high risk of developing such conditions to detect their condition at early stage, monitor it and personalise treatments. 

Benefits:
  • Measure and monitor chronic inflammatory processes in your body reliably 
  • Optimise your health trajectory 
  • Personalise and track effectiveness of  anti-inflammatory therapies.
BIOPHARMA, GLYCOANALYSIS, IBD, CLINICAL TRIALS PRECISION MEDICINE

Clinicians

We help:

Medical or other healthcare practitioners responsible for caring for patients with Chronic Inflammatory Diseases to improve patients outcome and personalise treatments. 

Benefits:
  • Reliable biomarkers for early detection, treatment personalisation, and tracking effectiveness of anti -inflammatory interventions
  • Enable more personalised and preventative approach to treat cID

Biopharma

We help: Drug companies developing anti-inflammatory therapeutics to improve cost effectiveness and efficiency of trials. 

Benefits:
  • MeasureEnhances  patient selection
  • Provides reliable  evidence of drug efficacy
  • Increases probability  of regulatory approval